GO TO: Recent Comment Letters
ALL |
All 10-K/Qs
Large
Mid
Small
Micro
|
Earnings Release
Proxy
|
SORT BY :
Most Recent
Company Name
| Company | Time | Size | View | Financials | Document | SEC | Period | Revenue MRQ | Assets | EPS Diluted | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | 8/14/2026 4:41:18 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2027 ending: 6/30/2026 | Rev: $1,476,000 +504.9% | Assets $35,736,000 | EPS -$0.30 | |
| Vistagen Therapeutics, Inc. (VTGN) | 8/14/2026 8:42:43 AM | View | Financials | Earnings | SEC | 1Q 2027 | Rev $1,476,000 +504.9% | Assets $35,736,000 | EPS -$0.30 | Export Earnings Model | |
| Vistagen Therapeutics, Inc. (VTGN) | 7/31/2026 4:11:20 PM | View | Proxy | SEC | Y 2026 | ||||||
| Vistagen Therapeutics, Inc. (VTGN) | 6/15/2026 5:02:37 PM | Micro | View | Financials | 10-K | SEC | Y 2026 ending: 3/31/2026 | Rev: $1,269,000 +161.1% | Assets $48,564,000 | EPS -$1.83 | |
| Vistagen Therapeutics, Inc. (VTGN) | 6/15/2026 4:36:38 PM | View | Financials | Earnings | SEC | Y 2026 | Rev $465,000 | Assets $48,564,000 | EPS -$0.37 | Export Earnings Model | |
| Vistagen Therapeutics, Inc. (VTGN) | 2/12/2026 4:41:37 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2026 ending: 12/31/2025 | Rev: $303,000 +29.5% | Assets $65,056,000 | EPS -$0.45 | |
| Vistagen Therapeutics, Inc. (VTGN) | 2/12/2026 4:36:52 PM | View | Financials | Earnings | SEC | 3Q 2026 | Rev $303,000 +29.5% | Assets $65,056,000 | EPS -$0.45 | Export Earnings Model | |
| Vistagen Therapeutics, Inc. (VTGN) | 11/13/2025 4:45:56 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2026 ending: 9/30/2025 | Rev: $258,000 +41.0% | Assets $80,929,000 | EPS -$0.54 | |
| Vistagen Therapeutics, Inc. (VTGN) | 11/13/2025 4:36:03 PM | View | Financials | Earnings | SEC | 2Q 2026 | Rev $258,000 +41.0% | Assets $80,929,000 | EPS -$0.54 | Export Earnings Model | |
| Vistagen Therapeutics, Inc. (VTGN) | 8/7/2025 5:02:29 PM | View | Financials | Earnings | SEC | 1Q 2026 | Rev $244,000 +190.5% | Assets $68,924,000 | EPS -$0.47 | Export Earnings Model | |
| Vistagen Therapeutics, Inc. (VTGN) | 8/7/2025 5:01:56 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2026 ending: 6/30/2025 | Rev: $244,000 +190.5% | Assets $68,924,000 | EPS -$0.47 | |
| Vistagen Therapeutics, Inc. (VTGN) | 7/28/2025 5:14:58 PM | View | Proxy | SEC | Y 2025 | ||||||
| Vistagen Therapeutics, Inc. (VTGN) | 6/17/2025 4:45:32 PM | View | Financials | Earnings | SEC | Y 2025 | Rev ($15,000) | Assets $84,341,000 | EPS -$0.44 | Export Earnings Model | |
| Vistagen Therapeutics, Inc. (VTGN) | 6/17/2025 4:42:09 PM | Micro | View | Financials | 10-K | SEC | Y 2025 ending: 3/31/2025 | Rev: $486,000 -54.3% | Assets $84,341,000 | EPS -$1.67 | |
| Vistagen Therapeutics, Inc. (VTGN) | 2/13/2025 5:32:31 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2025 ending: 12/31/2024 | Rev: $234,000 -43.1% | Assets $92,307,000 | EPS -$0.46 | |
| Vistagen Therapeutics, Inc. (VTGN) | 2/13/2025 4:46:41 PM | View | Financials | Earnings | SEC | 3Q 2025 | Rev $234,000 -43.1% | Assets $92,307,000 | EPS -$0.46 | Export Earnings Model | |
| Vistagen Therapeutics, Inc. (VTGN) | 11/7/2024 4:55:11 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2025 ending: 9/30/2024 | Rev: $183,000 -34.1% | Assets $102,496,000 | EPS -$0.42 | |
| Vistagen Therapeutics, Inc. (VTGN) | 11/7/2024 4:48:05 PM | View | Financials | Earnings | SEC | 2Q 2025 | Rev $183,000 -34.1% | Assets $102,496,000 | EPS -$0.42 | Export Earnings Model | |
| Vistagen Therapeutics, Inc. (VTGN) | 8/13/2024 5:05:10 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2025 ending: 6/30/2024 | Rev: $84,000 -52.5% | Assets $113,548,000 | EPS -$0.35 | |
| Vistagen Therapeutics, Inc. (VTGN) | 8/13/2024 4:54:47 PM | View | Financials | Earnings | SEC | 1Q 2025 | Rev $84,000 -52.5% | Assets $113,548,000 | EPS -$0.35 | Export Earnings Model | |
| Vistagen Therapeutics, Inc. (VTGN) | 7/17/2024 6:02:26 AM | View | Proxy | SEC | Y 2024 | ||||||
| Vistagen Therapeutics, Inc. (VTGN) | 6/11/2024 4:38:35 PM | Micro | View | Financials | 10-K | SEC | Y 2024 ending: 3/31/2024 | Rev: $1,064,000 | Assets $123,653,000 | EPS -$1.52 | |
| Vistagen Therapeutics, Inc. (VTGN) | 6/11/2024 4:29:08 PM | View | Financials | Earnings | SEC | Y 2024 | Rev $197,300 | Assets $123,653,000 | EPS -$0.58 | Export Earnings Model | |
| Vistagen Therapeutics, Inc. (VTGN) | 4/16/2024 6:05:08 AM | View | Proxy | SEC | Y 2024 | ||||||
| Vistagen Therapeutics, Inc. (VTGN) | 2/13/2024 4:39:45 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2024 ending: 12/31/2023 | Rev: $411,400 | Assets $131,068,000 | ||
| Vistagen Therapeutics, Inc. (VTGN) | 2/13/2024 4:36:47 PM | View | Financials | Earnings | SEC | 3Q 2024 | Rev $411,400 | Assets $131,068,000 | Export Earnings Model | ||
| Vistagen Therapeutics, Inc. (VTGN) | 11/9/2023 4:57:44 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2024 ending: 9/30/2023 | Rev: $277,700 -68.9% | Assets $42,195,800 | ||
| Vistagen Therapeutics, Inc. (VTGN) | 11/9/2023 4:45:04 PM | View | Financials | Earnings | SEC | 2Q 2024 | Rev $277,700 -68.9% | Assets $42,195,800 | Export Earnings Model | ||
| Vistagen Therapeutics, Inc. (VTGN) | 8/10/2023 5:14:46 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2024 ending: 6/30/2023 | Rev: $177,000 -42.9% | Assets $15,032,300 | EPS -$0.94 | |
| Vistagen Therapeutics, Inc. (VTGN) | 8/10/2023 4:52:25 PM | View | Financials | Earnings | SEC | 1Q 2024 | Rev $177,000 -42.9% | Assets $15,032,300 | EPS -$0.94 | Export Earnings Model | |
| Vistagen Therapeutics, Inc. (VTGN) | 7/28/2023 4:56:04 PM | View | Proxy | SEC | Y 2023 | ||||||
| Vistagen Therapeutics, Inc. (VTGN) | 6/28/2023 5:26:49 PM | Micro | View | Financials | 10-K | SEC | Y 2023 ending: 3/31/2023 | Assets $21,089,000 | EPS -$8.51 | ||
| Vistagen Therapeutics, Inc. (VTGN) | 6/28/2023 4:29:01 PM | View | Financials | Earnings | SEC | Y 2023 | Assets $21,089,000 | EPS -$8.51 | Export Earnings Model | ||
| VistaGen Therapeutics, Inc. (VTGN) | 2/7/2023 4:30:42 PM | View | Financials | Earnings | SEC | 3Q 2023 | Rev ($179,600) | Assets $29,708,800 | Export Earnings Model | ||
| VistaGen Therapeutics, Inc. (VTGN) | 2/7/2023 4:28:16 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2023 ending: 12/31/2022 | Assets $29,708,800 | |||
| VistaGen Therapeutics, Inc. (VTGN) | 11/10/2022 4:43:41 PM | View | Financials | Earnings | SEC | 2Q 2023 | Rev $892,500 +149.3% | Assets $40,701,700 | Export Earnings Model | ||
| VistaGen Therapeutics, Inc. (VTGN) | 11/10/2022 4:38:22 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2023 ending: 9/30/2022 | Rev: $892,500 +149.3% | Assets $40,701,700 | ||
| VistaGen Therapeutics, Inc. (VTGN) | 8/31/2022 4:53:36 PM | View | Proxy | SEC | Y 2022 | ||||||
| VistaGen Therapeutics, Inc. (VTGN) | 8/11/2022 4:27:47 PM | View | Financials | Earnings | SEC | 1Q 2023 | Rev $310,100 -12.4% | Assets $58,725,600 | Export Earnings Model | ||
| VistaGen Therapeutics, Inc. (VTGN) | 8/11/2022 4:25:41 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2023 ending: 6/30/2022 | Rev: $310,100 -12.4% | Assets $58,725,600 | ||
| VistaGen Therapeutics, Inc. (VTGN) | 6/23/2022 4:31:53 PM | View | Financials | Earnings | SEC | Y 2022 | Rev $38,900 -91.2% | Assets $74,643,400 | Export Earnings Model | ||
| VistaGen Therapeutics, Inc. (VTGN) | 6/23/2022 4:29:46 PM | Micro | View | Financials | 10-K | SEC | Y 2022 ending: 3/31/2022 | Rev: $1,108,900 +1.8% | Assets $74,643,400 | ||
| VistaGen Therapeutics, Inc. (VTGN) | 2/10/2022 4:20:58 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2022 ending: 12/31/2021 | Rev: $357,900 +14.1% | Assets $90,536,100 | EPS -$0.05 | |
| VistaGen Therapeutics, Inc. (VTGN) | 2/10/2022 4:20:31 PM | View | Financials | Earnings | SEC | 3Q 2022 | Rev $357,900 +14.1% | Assets $90,536,100 | EPS -$0.05 | Export Earnings Model | |
| VistaGen Therapeutics, Inc. (VTGN) | 11/10/2021 5:28:29 PM | View | Financials | Earnings | SEC | 2Q 2022 | Rev $358,000 +7.2% | Assets $100,499,700 | EPS -$0.07 | Export Earnings Model | |
| VistaGen Therapeutics, Inc. (VTGN) | 11/10/2021 4:22:57 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2022 ending: 9/30/2021 | Rev: $358,000 +7.2% | Assets $100,499,700 | EPS -$0.07 | |
| VistaGen Therapeutics, Inc. (VTGN) | 8/12/2021 4:59:43 PM | View | Financials | Earnings | SEC | 1Q 2022 | Rev $354,100 | Assets $103,907,200 | Export Earnings Model | ||
| VistaGen Therapeutics, Inc. (VTGN) | 8/12/2021 4:24:02 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2022 ending: 6/30/2021 | Rev: $354,100 | Assets $103,907,200 | ||
| VistaGen Therapeutics, Inc. (VTGN) | 7/29/2021 5:16:36 PM | View | Proxy | SEC | Y 2021 | ||||||
| VistaGen Therapeutics, Inc. (VTGN) | 6/29/2021 4:12:36 PM | Micro | View | Financials | 10-K | SEC | Y 2021 ending: 3/31/2021 | Rev: $1,089,500 | Assets $108,281,300 | ||
| VistaGen Therapeutics, Inc. (VTGN) | 6/29/2021 4:09:58 PM | View | Financials | Earnings | SEC | Y 2021 | Rev $441,900 | Assets $108,281,300 | Export Earnings Model | ||
| VistaGen Therapeutics, Inc. (VTGN) | 2/12/2021 4:06:57 PM | View | Financials | Earnings | SEC | 3Q 2021 | Rev $313,600 | Assets $109,271,100 | EPS -$0.07 | Export Earnings Model | |
| VistaGen Therapeutics, Inc. (VTGN) | 2/11/2021 4:44:30 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2021 ending: 12/31/2020 | Rev: $313,600 | Assets $109,271,100 | EPS -$0.07 | |
| VistaGen Therapeutics, Inc. (VTGN) | 1/14/2021 4:48:34 PM | View | Proxy | SEC | Y 2020 | ||||||
| VistaGen Therapeutics, Inc. (VTGN) | 11/16/2020 6:23:09 AM | View | Financials | Earnings | SEC | 2Q 2021 | Rev $334,000 | Assets $20,270,700 | EPS -$0.05 | Export Earnings Model | |
| VistaGen Therapeutics, Inc. (VTGN) | 11/12/2020 4:41:49 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2021 ending: 9/30/2020 | Rev: $334,000 | Assets $20,270,700 | EPS -$0.05 | |
| VistaGen Therapeutics, Inc. (VTGN) | 8/14/2020 5:26:07 PM | View | Financials | Earnings | SEC | 1Q 2021 | Rev $0 | Assets $6,166,900 | EPS -$0.07 | Export Earnings Model | |
| VistaGen Therapeutics, Inc. (VTGN) | 8/13/2020 4:33:41 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2021 ending: 6/30/2020 | Assets $6,166,900 | EPS -$0.07 | ||
| VistaGen Therapeutics, Inc. (VTGN) | 7/27/2020 4:52:46 PM | View | Proxy | SEC | Y 2020 | ||||||
| VistaGen Therapeutics, Inc. (VTGN) | 6/30/2020 4:17:52 PM | View | Financials | Earnings | SEC | Y 2020 | Rev $0 | Assets $5,772,300 | EPS -$0.08 | Export Earnings Model | |
| VistaGen Therapeutics, Inc. (VTGN) | 6/30/2020 6:44:27 AM | Micro | View | Financials | 10-K | SEC | Y 2020 ending: 3/31/2020 | Assets $5,772,300 | EPS -$0.50 | ||
| VistaGen Therapeutics, Inc. (VTGN) | 2/13/2020 4:45:42 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2020 ending: 12/31/2019 | Assets $5,330,800 | EPS -$0.15 | ||
| VistaGen Therapeutics, Inc. (VTGN) | 2/13/2020 4:40:58 PM | View | Financials | Earnings | SEC | 3Q 2020 | Rev $0 | Assets $5,330,800 | EPS -$0.15 | Export Earnings Model | |
| VistaGen Therapeutics, Inc. (VTGN) | 11/8/2019 6:09:02 AM | View | Financials | Earnings | SEC | 2Q 2020 | Rev $0 | Assets $8,735,500 | EPS -$0.13 | Export Earnings Model | |
| VistaGen Therapeutics, Inc. (VTGN) | 11/7/2019 6:49:56 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2020 ending: 9/30/2019 | Assets $8,735,500 | EPS -$0.13 | ||
| VistaGen Therapeutics, Inc. (VTGN) | 8/16/2019 4:10:58 PM | View | Financials | Earnings | SEC | 1Q 2020 | Rev $16,000 | Assets $12,947,300 | EPS -$0.15 | Export Earnings Model | |
| VistaGen Therapeutics, Inc. (VTGN) | 8/13/2019 4:49:13 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2020 ending: 6/30/2019 | Rev: $16,000 | Assets $12,947,300 | EPS -$0.15 | |
| VistaGen Therapeutics, Inc. (VTGN) | 7/23/2019 5:14:28 PM | View | Proxy | SEC | Y 2019 | ||||||
| VistaGen Therapeutics, Inc. (VTGN) | 6/25/2019 4:31:52 PM | Micro | View | Financials | 10-K | SEC | Y 2019 ending: 3/31/2019 | Assets $14,011,700 | EPS -$0.90 | ||
| VistaGen Therapeutics, Inc. (VTGN) | 2/12/2019 5:09:20 PM | View | Financials | Earnings | WIRE | 3Q 2019 | Assets $7,521,800 | EPS -$0.24 | Export Earnings Model | ||
| VistaGen Therapeutics, Inc. (VTGN) | 2/12/2019 4:54:00 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2019 ending: 12/31/2018 | Assets $7,521,800 | EPS -$0.24 | ||
| VistaGen Therapeutics, Inc. (VTGN) | 10/30/2018 4:38:46 PM | View | Financials | Earnings | SEC | 2Q 2019 | Assets $8,889,200 | EPS -$0.30 | Export Earnings Model | ||
| VistaGen Therapeutics, Inc. (VTGN) | 10/29/2018 5:04:21 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2019 ending: 9/30/2018 | Assets $8,889,200 | EPS -$0.30 | ||
| VistaGen Therapeutics, Inc. (VTGN) | 8/15/2018 4:00:39 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2019 ending: 6/30/2018 | Assets $8,255,300 | EPS -$0.20 | ||
| VistaGen Therapeutics, Inc. (VTGN) | 7/27/2018 4:04:22 PM | View | Proxy | SEC | Y 2018 | ||||||
| VistaGen Therapeutics, Inc. (VTGN) | 6/27/2018 2:10:58 PM | View | Financials | Earnings | SEC | Y 2018 | Assets $11,278,300 | EPS -$0.19 | Export Earnings Model | ||
| VistaGen Therapeutics, Inc. (VTGN) | 6/26/2018 5:16:56 PM | Micro | View | Financials | 10-K | SEC | Y 2018 ending: 3/31/2018 | Assets $11,278,300 | EPS -$1.12 | ||
| VistaGen Therapeutics, Inc. (VTGN) | 2/13/2018 6:32:58 AM | View | Financials | Earnings | SEC | 3Q 2018 | Assets $14,242,800 | EPS -$0.25 | Export Earnings Model | ||
| VistaGen Therapeutics, Inc. (VTGN) | 2/12/2018 4:44:47 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2018 ending: 12/31/2017 | Assets $14,242,800 | EPS -$0.25 | ||
| VistaGen Therapeutics, Inc. (VTGN) | 11/9/2017 4:43:57 PM | View | Financials | Earnings | SEC | 2Q 2018 | Assets $2,617,500 | EPS -$0.53 | Export Earnings Model | ||
| VistaGen Therapeutics, Inc. (VTGN) | 11/9/2017 4:42:55 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2018 ending: 9/30/2017 | Assets $2,617,500 | EPS -$0.53 | ||
| VistaGen Therapeutics, Inc. (VTGN) | 8/14/2017 4:45:08 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2018 ending: 6/30/2017 | Assets $2,436,900 | EPS -$0.28 | ||
| VistaGen Therapeutics, Inc. (VTGN) | 8/14/2017 4:39:57 PM | View | Financials | Earnings | SEC | 1Q 2018 | Assets $2,436,900 | EPS -$0.28 | Export Earnings Model | ||
| VistaGen Therapeutics, Inc. (VTGN) | 8/4/2017 2:15:20 PM | View | Proxy | SEC | Y 2017 | ||||||
| VistaGen Therapeutics, Inc. (VTGN) | 6/29/2017 4:50:08 PM | View | Financials | Earnings | SEC | Y 2017 | Rev $0 | Assets $3,712,200 | EPS -$0.32 | Export Earnings Model | |
| VistaGen Therapeutics, Inc. (VTGN) | 6/29/2017 6:15:59 AM | Micro | View | Financials | 10-K | SEC | Y 2017 ending: 3/31/2017 | Rev: $2,500,000 | Assets $3,712,200 | EPS -$1.54 | |
| VistaGen Therapeutics, Inc. (VTGN) | 2/13/2017 4:28:43 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2017 ending: 12/31/2016 | Rev: $2,500,000 | Assets $5,876,100 | EPS -$0.34 | |
| VistaGen Therapeutics, Inc. (VTGN) | 11/15/2016 5:30:00 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2017 ending: 9/30/2016 | Assets $7,023,000 | EPS -$0.42 | ||
| VistaGen Therapeutics, Inc. (VTGN) | 11/14/2016 4:46:50 PM | View | Financials | Earnings | SEC | 2Q 2017 | Assets $7,023,000 | EPS -$0.42 | Export Earnings Model | ||
| VistaGen Therapeutics, Inc. (VTGN) | 8/12/2016 4:06:20 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2017 ending: 6/30/2016 | Assets $8,757,800 | EPS -$0.51 | ||
| VistaGen Therapeutics, Inc. (VTGN) | 8/5/2016 5:46:46 PM | View | Proxy | SEC | Y 2016 | ||||||
| VistaGen Therapeutics, Inc. (VTGN) | 6/24/2016 5:10:33 PM | Micro | View | Financials | 10-K | SEC | Y 2016 ending: 3/31/2016 | Assets $989,800 | EPS -$29.08 | ||
| VistaGen Therapeutics, Inc. (VTGN) | 2/16/2016 4:04:28 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2016 ending: 12/31/2015 | Assets $2,012,200 | EPS -$1.95 | ||
| VistaGen Therapeutics, Inc. (VTGN) | 11/16/2015 5:30:00 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2016 ending: 9/30/2015 | Assets $1,932,500 | EPS -$5.26 | ||
| VistaGen Therapeutics, Inc. (VTGN) | 8/14/2015 4:02:24 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2016 ending: 6/30/2015 | Assets $1,743,800 | EPS -$19.23 | ||
| VistaGen Therapeutics, Inc. (VTGN) | 8/11/2015 12:34:51 PM | View | Proxy | SEC | Y 2015 | ||||||
| VistaGen Therapeutics, Inc. (VTGN) | 6/29/2015 5:29:54 PM | Micro | View | Financials | 10-K | SEC | Y 2015 ending: 3/31/2015 | Assets $269,700 | EPS -$10.61 | ||
| VistaGen Therapeutics, Inc. (VTGN) | 2/17/2015 4:19:55 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2015 ending: 12/31/2014 | Assets $259,400 | EPS -$1.08 | ||
| VistaGen Therapeutics, Inc. (VTGN) | 11/19/2014 4:36:00 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2015 ending: 9/30/2014 | Assets $386,900 | EPS -$1.90 | ||
| VistaGen Therapeutics, Inc. (VTGN) | 8/12/2014 4:36:06 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2015 ending: 6/30/2014 | Assets $764,700 | EPS -$3.70 | ||
| VistaGen Therapeutics, Inc. (VTGN) | 6/25/2014 6:14:46 AM | Micro | View | Financials | 10-K | SEC | Y 2014 ending: 3/31/2014 | Assets $263,700 | EPS -$3.81 | ||
| VistaGen Therapeutics, Inc. (VTGN) | 2/14/2014 4:08:05 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2014 ending: 12/31/2013 | Assets $328,900 | EPS -$0.44 | ||
| VistaGen Therapeutics, Inc. (VTGN) | 11/14/2013 4:14:25 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2014 ending: 9/30/2013 | Assets $406,000 | EPS -$1.37 | ||
| VistaGen Therapeutics, Inc. (VTGN) | 8/14/2013 5:49:54 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2014 ending: 6/30/2013 | Assets $431,800 | EPS -$0.44 | ||
| VistaGen Therapeutics, Inc. (VTGN) | 7/18/2013 7:25:36 AM | Micro | View | Financials | 10-K | SEC | Y 2013 ending: 3/31/2013 | Assets $263,700 | EPS -$0.02 | ||
| VistaGen Therapeutics, Inc. (VTGN) | 2/14/2013 4:37:03 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2013 ending: 12/31/2012 | Assets $326,000 | EPS -$0.85 | ||
| VistaGen Therapeutics, Inc. (VTGN) | 11/14/2012 4:02:37 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2013 ending: 9/30/2012 | Assets $424,600 | EPS -$0.11 | ||
| VistaGen Therapeutics, Inc. (VTGN) | 8/14/2012 8:02:20 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2013 ending: 6/30/2012 | Rev: $200,400 -63.9% | Assets $645,000 | EPS -$0.11 | |
| VistaGen Therapeutics, Inc. (VTGN) | 7/2/2012 5:10:45 PM | Micro | View | Financials | 10-K | SEC | Y 2012 ending: 3/31/2012 | Assets $881,500 | EPS -$0.83 | ||
| VistaGen Therapeutics, Inc. (VTGN) | 2/14/2012 5:30:00 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2012 ending: 12/31/2011 | Rev: $2,000 -99.7% | Assets $399,717 | EPS -$0.28 | |
| VistaGen Therapeutics, Inc. (VTGN) | 11/14/2011 6:22:29 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2012 ending: 9/30/2011 | Rev: $316,000 -20.9% | Assets $537,290 | EPS -$0.15 | |
| VistaGen Therapeutics, Inc. (VTGN) | 10/11/2011 7:40:26 PM | View | Proxy | SEC | Y 2011 | ||||||
| VistaGen Therapeutics, Inc. (VTGN) | 8/22/2011 2:32:56 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2012 ending: 6/30/2011 | Rev: $555,000 -24.4% | Assets $1,684,503 | EPS -$0.22 |